Close

Baird Downgrades Pharmasset (VRUS) to Neutral; Sticking with INHX on Derivative Weakness Dec 16, 2011 10:56AM
Baird Maintains an 'Outperform' on Inhibitex (INHX); Positive Updates on '189 Profile and Balance Sheet Nov 29, 2011 11:02AM
Baird Maintains an 'Outperform' on Pharmasset (VRUS); First Impression: Positive for Both Companies and the Space Nov 21, 2011 11:01AM
Baird Starts Inhibitex (INHX) at Outperform; Pure Play in a HCV Sweet Spot Aug 25, 2011 07:24AM